日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

First-line enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma-commentary on patient-reported outcomes in EV-302

一线恩福妥单抗联合帕博利珠单抗治疗局部晚期或转移性尿路上皮癌——EV-302研究中患者报告结局的评论

期刊:Translational Andrology and Urology
影响因子:1.7
doi:10.21037/tau-2025-733
Liedberg, Fredrik; Ståhl, Olof; Bobjer, Johannes
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Secondary Colonic Adenocarcinoma After Continent Cutaneous Urinary Diversion a.m. Lundiana-An Aggressive Disease Entity With High Risk of Locally Advanced Disease and Metastases

经尿道尿流改道术后继发性结肠腺癌——一种侵袭性疾病，具有较高的局部晚期和转移风险

期刊:IJU Case Reports
影响因子:0.6
doi:10.1002/iju5.70186
Liedberg, Fredrik; Bläckberg, Mats; Bobjer, Johannes
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Bladder cancer subtypes exhibit limited plasticity across different microenvironments and in metastases.

膀胱癌亚型在不同的微环境和转移灶中表现出有限的可塑性

期刊:Experimental Hematology & Oncology
影响因子:13.5
doi:10.1186/s40164-025-00682-z
Bernardo Carina, Chattopadhyay Subhayan, Andersson Natalie, Eriksson Pontus, Medle Benjamin, Tran Lena, Dain Marzouka Nour Al, Mattsson Adam, Zadoroznyj Aymeric, Larsson Malin, Liedberg Fredrik, Höglund Mattias, Sjödahl Gottfrid
肿瘤
发表日期：2025
文献求助 收藏

Exploring novel genomic biomarkers for response and survival after neoadjuvant chemotherapy and radical cystectomy of muscle-invasive bladder cancer

探索肌层浸润性膀胱癌新辅助化疗和根治性膀胱切除术后疗效和生存的新型基因组生物标志物

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105512
Holmsten, K; De Laere, B; Sjödahl, G; Lindberg, J; Costa Svedman, F; Östling, P; Eriksson, P; Liedberg, F; Ullén, A
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

Applicability of the European Association of Urology 2021 Prognostic Model for Non-muscle-invasive Bladder Cancer in a Swedish Population-based Cohort

欧洲泌尿外科协会2021年非肌层浸润性膀胱癌预后模型在瑞典人群队列中的适用性

期刊:European Urology Open Science
影响因子:4.5
doi:10.1016/j.euros.2025.08.003
Liedberg, Fredrik; Hagberg, Oskar; Beijert, Irene J; Aljabery, Firas; Gårdmark, Truls; Hosseini, Abolfazl; Jahnson, Staffan; Jerlström, Tomas; Kjölhede, Henrik; Malmström, Per-Uno; Ströck, Viveka; Söderkvist, Karin; Ullén, Anders; van Rhijn, Bas W G; Holmberg, Lars; Häggström, Christel
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

Incidence and risk factors for postoperative vaginal events following radical cystectomy for bladder cancer: a nationwide population-based study

膀胱癌根治性膀胱切除术后阴道并发症的发生率和危险因素：一项全国性人群研究

期刊:Bju International
影响因子:4.4
doi:10.1111/bju.70004
Kalén, Elin; Ginstman, Charlotte; Liedberg, Fredrik; Hagberg, Oskar; Holmbom, Martin; Jerlström, Tomas; Jahnson, Staffan; Gårdmark, Truls; Ströck, Viveka; Holmberg, Lars; Häggström, Christel; Aljabery, Firas
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

Evaluation of the clinical use of a digital support app for employees with musculoskeletal pain and their employers in an industrial workplace. A mixed methods study

评估一款面向工业企业中患有肌肉骨骼疼痛的员工及其雇主的数字支持应用程序的临床应用效果。一项混合方法研究

期刊:DIGITAL HEALTH
影响因子:3.3
doi:10.1177/20552076251342014
Liedberg, Gunilla M; Björk, Mathilda; Karlsson, Linn; Turesson, Christina
发表日期：2025
文献求助 收藏

Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting

在瑞典，针对肌层浸润性膀胱癌患者，根据分子亚型降低新辅助化疗强度的成本效益分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1556881
Saha, Sanjib; Gerdtham, Ulf-Göran; Sjödahl, Gottfrid; Häggström, Christel; Catto, James W F; Kelly, John D; Ullén, Anders; Holmberg, Lars; Liedberg, Fredrik
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

Calendar time trends in synchronous metastatic urinary bladder cancer before and after the introduction of immune checkpoint inhibitors: a nation-wide population-based cohort study

免疫检查点抑制剂应用前后同步转移性膀胱癌的日历时间趋势：一项全国性人群队列研究

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1680916
Söderkvist, Karin; Häggström, Christel; Hagberg, Oskar; Aljabery, Firas; Gårdmark, Truls; Holmberg, Lars; Hosseini, Abolfazl; Jerlström, Tomas; Kjölhede, Henrik; Malmström, Per-Uno; Sherif, Amir; Liedberg, Fredrik; Ullén, Anders
肿瘤
肿瘤免疫
膀胱癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Lower MeDiC score is associated with non-referral to multidisciplinary team meeting discussion in bladder cancer patients: a nationwide and population-based study

一项全国性、基于人群的研究表明，膀胱癌患者中，较低的MeDiC评分与未转诊至多学科团队会议讨论相关。

期刊:Acta Oncologica
影响因子:2.2
doi:10.2340/1651-226X.2025.42756
Wihl, Jessica; Oskar Hagberg; Firas Aljabery; Truls Gårdmark; Abolfazl Hosseini; Staffan Jahnson; Tomas Jerlström; Viveka Ströck; Karin Söderkvist; Anders Ullén; Lars Holmberg; Christel Häggström; Fredrik Liedberg
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏